Teleflex Incorporated (TFX)
Teleflex (TFX) Tops Q2 Earnings Estimates, Raises 2024 Outlook
Teleflex's (TFX) diversified portfolio and global footprint have driven durable growth in the second quarter of 2024.
Teleflex Incorporated (TFX) Q2 2024 Earnings Call Transcript
Teleflex Incorporated (NYSE:TFX ) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer Thomas Powell - Executive Vice President & Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Group Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC George Sellers - Stephens Inc Rich Newitter - Truist Mike Polark - Wolfe Craig Bijou - Bank of America Dave Turkaly - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Second Quarter 2024 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode.
Compared to Estimates, Teleflex (TFX) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Teleflex (TFX) Q2 Earnings Surpass Estimates
Teleflex (TFX) came out with quarterly earnings of $3.42 per share, beating the Zacks Consensus Estimate of $3.33 per share. This compares to earnings of $3.41 per share a year ago.
Teleflex raises 2024 profit forecast on medical device demand
Surgical equipment maker Teleflex raised its annual profit forecast on Thursday, banking on resilient demand for certain surgical procedures at hospitals to drive sales for its medical devices.
What Analyst Projections for Key Metrics Reveal About Teleflex (TFX) Q2 Earnings
Get a deeper insight into the potential performance of Teleflex (TFX) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: Teleflex (TFX) Q2 Earnings Expected to Decline
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Makes Teleflex (TFX) a New Buy Stock
Teleflex (TFX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TFX vs. SONVY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks presents investors with the better value opportunity right now?
This Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
Teleflex Inc TFX benefited in the first quarter from the surge in the interventional segment and other tailwinds.
Is it Wise to Hold Teleflex (TFX) Stock in Your Portfolio Now?
Teleflex (TFX) holds strong momentum in the Interventional arm and a favorable solvency. Yet, macroeconomic impacts and competitive environment trigger concerns.
US FDA classifies recall of Teleflex's inflatable devices as 'most serious'
The U.S. Food and Drug Administration classified a recall of Teleflex's inflatable devices that increase blood supply to the heart muscle as "most serious".
